Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

Affiliations

• ¹ The Ludwig Center, Johns Hopkins University, Baltimore, Maryland, USA.
• ² Howard Hughes Medical Institute, Johns Hopkins University, Baltimore, Maryland, USA.
• ³ Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
• ⁴ Department of Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
• ⁵ Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
• ⁶ Department of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA.
• ⁷ Department of Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
• ⁸ Department of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
• ⁹ Department of Pathology, University Medical Center, Utrecht, The Netherlands.
• ¹⁰ Department of Pathology, Universidad de La Frontera, Temuco, Chile.
• ¹¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
• ¹² Dan Setlacec Center of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
• ¹³ Applied Research on Cancer Network, Miriam Cherubini Research Centre, University of Verona, Verona, Italy.
• ¹⁴ Department of Pathology and Diagnostics, University of Verona, Verona, Italy.
• ¹⁵ Department of Surgery, University of Verona, Verona, Italy.
• ¹⁶ Department of Medicine, Medical Oncology Unit, University of Verona, Verona, Italy.
• ¹⁷ Medical Oncology Unit 1, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy.
• ¹⁸ Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
• ¹⁹ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.